PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Federal Office for Civil Protection, Spiez Laboratory, Spiez, Switzerland.\', \'ADMed Microbiologie, La-Chaux-de-Fonds, Switzerland.\', \'Commission of Clinical Microbiology (CCCM) of the Swiss Society of Microbiology.\', \'Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland.\', \'Applied Microbiology Research, Department Biomedicine, University of Basel, Basel, Switzerland.\', \'Federal Office of Public Health, Bern, Switzerland.\', \'Institute for Medical Microbiology, University Hospital Lausanne, Lausanne, Switzerland.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.4414/smw.2021.w30120Swiss Med Wkly. 2021;151:w30120
?:doi
?:hasPublicationType
?:journal
  • Swiss medical weekly
is ?:pmid of
?:pmid
?:pmid
  • 34909869
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.8
?:rankingScore_hIndex
  • 62
?:title
  • PCR performance in the SARS-CoV-2 Omicron variant of concern?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all